期刊文献+

天然调节性T细胞的调节因素研究进展 被引量:6

Main Regulatory Factors for Differentiation, Development and Function of Naturally Occurred CD4^+CD25^+ Regulatory T Cells——Review
在线阅读 下载PDF
导出
摘要 天然CD4+CD25+调节T细胞来源于胸腺,通过直接接触机制抑制效应细胞的增殖,调节自身免疫和移植免疫。本文主要综述了影响天然调节T细胞分化、发育和功能的主要因素和可能机制。Foxp3是Treg的标志,检测其表达可以作为判定Treg的方法。IL-2主要通过IL-2Rα及STAT5途径促进Treg的增殖活化。膜型和分泌型TGF-β具有不同功能,膜型TGF-β1可能主要介导Treg的抑制功能,而分泌型TGF-β可能主要促进Treg的增殖。树突状细胞由于作用途径不同,对Treg既有正调节,也有负调节。CTLA-4途径可能通过作用于Treg自身、DC或效应细胞直接或间接地调节Treg的功能。 Naturally occurred CD4 ^+ CD25 ^+ regulatory T cells derived from thymus. It plays an important role in self-tolerance and allograft-tolerance through cell-contact dependent mechanism. This review described the advances of study on the probable regulatory factors of the naturally occurring regulatory T cells, such as Foxp3, IL-2, TGF-β1, dendritic cells and CTLA-4. As a marker of Treg, the expression of Foxp3 could be used to identify regulatory T cells. The combination of interferon 2 and IL-2Rα would activate Treg and promote its proliferation through the phosphorylation of STATS . TGF-β1 on the cell surface may influence the function of Treg, while the secretion type of TGF-β may promote the proliferation of Treg, Dendritic cells can positively or negtively regulate Treg, which depends on the signal transduction pathway. CTLA-4 expressed on the surface of Treg might bind to the B7 molecule on the DC, effective cell or Treg itself directly or indirectly regulate Treg.
作者 吴敏 谢彦晖
出处 《中国实验血液学杂志》 CAS CSCD 2008年第1期207-212,共6页 Journal of Experimental Hematology
关键词 天然CD4^+CD25^+调节T细胞 FOXP3 IL-2 TGF-Β1 树突状细胞 CTLA-4 naturally occurred CD4 ^+ CD25 ^+ regulatory T cell Foxp3 IL-2 TGF-β1 dendritic cell CTLA-4
作者简介 通讯作者:谢彦晖,教授.电话:(021)62489999—6102.E-mail:yahhuixie@163.com
  • 相关文献

参考文献37

  • 1Suri-Payer E, Amar AZ, Thornton AM, et al, CD4^+ CD25^+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells, J Immunol, 1998 ; 160 : 1212-1218.
  • 2Papiemik M, de-Moraes ML, Pontoux C, et al, Regulatory CD4 T cells: expression of IL-2R-α chain, resistance to clonal deletion and IL-2 dependency. Int Immunol, 1998 ; 10 : 371-378.
  • 3Bensinger SJ, Bandeira A, Jordan MS, et al, Major histocompatibility complex class-Ⅱ-positive cortical epithelium mediates the selection of CD4^+ CD25^+ immunoregulatory T cells. J Exp Med, 2001 ; 194:427-438.
  • 4Jordan MS, Boesteanu A, Reed AJ, et al, Thymic selection of CD4^+ CD25^+ regulatory T cells induced by an agonist self-peptide. Nat Immunol,2001 ;2:301-306.
  • 5van-Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells, J Exp Med, 2004, 200:1221-1230.
  • 6Fehervari Z, Sakaguchi S. CD4^+ Tregs and immune conatrol. J Clin Invest,2004; 114:1209-1217.
  • 7Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25^+ CD4^+ regulatory T cells by antigen-processing dendritic cells. J Exp Med, 2003; 198:235-247.
  • 8Nakamura K, Kitani A, Strober W. Cell contact -dependent immunosuppression by CD4^+ CD25^+ regulatory T cells is mediated by cell surface -bound transforming growth factor-β1. J Exp Med, 2001 ; 194:629-644.
  • 9Annunziato F, Cosmi L, Liotta F, et al. Phenotype, localization, and mechanism of suppression of CD4^+ CD25^+ human thymocytes. J Exp Med,2002;196:379-387.
  • 10Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol, 2003 ; 3: 189-198.

同被引文献64

  • 1欧媛,朱平.CD4^+CD25^+和CD8^+调节性T细胞的作用机制[J].中国实验血液学杂志,2005,13(6):1137-1140. 被引量:8
  • 2李霄,窦科峰,刘海亮,张福琴,蔡磊.体外联合应用IL-10和甲基强的松龙处理树突状细胞诱导移植的免疫耐受[J].细胞与分子免疫学杂志,2007,23(5):436-438. 被引量:3
  • 3Ball LM, Egeler RM. EBMT Paediatric Working Party. Acute GVHD : pathogenesis and clas- sification. Bone Marrow Transplant,2008 ;41 ( Suppl 2 ) : S58 - S64.
  • 4Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self- tolerance maintained by activated T ceils expressing IL-2 receptor a-chains (CD25). Breackdown of single mechanism of self- tolerance causes various autoimmune diseases. J Immunol, 1995 ; 155(3) : 1151 -1164.
  • 5Trenado A. Charlotte F, Fisson S, et al. Recipient-type specific CD4^+ CD25^+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versusleukemia. J Clin Invest, 2003 ; 112 ( 11 ) : 1688 - 1696.
  • 6Cohen JL, Trenado A, Vasey D, et al. CD4^+ CD25^+ immunoregulatory T cells:new therapeutics for graft-versus-host disease. J Exp Med,2002,196 ( 3 ) :401 - 406.
  • 7Reddy P, Ferrara JL. Immunobiology of acute graft-versus-host disease. Blood Rev, 2003 ;17(4) : 187 -194.
  • 8Ju XP, Xu B, Xiao ZP, et al. Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation. Bone Marrow Transplant, 2005 ; 35 ( 12 ) : 1179 - 1186.
  • 9Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4^+ CD25^+ immuneregulatory cells inhibits graft- versus-host disease lethality. Blood, 2002 ; 99 : 3493 - 3499.
  • 10Miura Y, Thobum C J, Bright EC, et al. Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood, 2004;104 (7): 2187-2193.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部